A theoretical approach to zonation in a bioartificial liver

Biotechnology and Bioengineering

Volumn 109, Issue 1, 2012, Pages 234-243

  Davidson, Adam J ^a   Ellis, Marianne J ^a   Chaudhuri, Julian B ^a  

^a University of Bath   (United Kingdom)

Author keywords

Bioartifical liver; Hepatocyte; Modeling; Zonation

Indexed keywords

BIOARTIFICIAL LIVER; BIOARTIFICIAL LIVER DEVICES; BIOREACTOR DESIGN; CELL VOLUME; DESIGN OPTIMIZATION; DESIGN PARAMETERS; HEPATOCYTES; IN-VITRO; IN-VIVO; LIVER CELLS; METABOLIC ACTIVITY; OPERATING PARAMETERS; OPERATING REGIONS; OXYGEN TENSION; THEORETICAL APPROACH; THEORETICAL MODELS; ZONATION;

ARTIFICIAL ORGANS; CELLS; DESIGN; MODELS; OPTIMIZATION;

METABOLISM;

ARTICLE; BIOARTIFICIAL LIVER; BIOREACTOR; CELL COUNT; FLOW RATE; HUMAN; IN VITRO STUDY; METABOLISM; OXYGEN TENSION; PLASMA; ZONATION;

EQUIPMENT DESIGN; HEPATOCYTES; LIVER; LIVER, ARTIFICIAL; MODELS, THEORETICAL; OXYGEN;

EID: 81455154357     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.23279     Document Type: Article

References (38)

1. Abdullah NS, Jones DR, Das DB. 2009. Nutrient transport in bioreactors for bone tissue growth: Why do hollow fibre membrane bioreactors work? Chem Eng Sci 64(1): 109-125.
2. Allen JW, Bhatia SN. 2003. Formation of steady-state oxygen gradients in vitro-Application to liver zonation. Biotechnol Bioeng 82(3): 253-262.
3. Allen JW, Hassanein T, Bhatia SN. 2001. Advances in bioartificial liver devices. Hepatology 34(3): 447-455.
4. Allen JW, Khetani SR, Bhatia SN. 2005. In vitro zonation and toxicity in a hepatocyte bioreactor. Toxicol Sci 84(1): 110-119.
5. Chen G, Palmer AF. 2009. Hemoglobin-based oxygen carrier and convection enhanced oxygen transport in a hollow fiber bioreactor. Biotechnol Bioeng 102(6): 1603-1612.
6. Chen G, Palmer AF. 2010. Mixtures of hemoglobin-based oxygen carriers and perfluorocarbons exhibit a synergistic effect in oxygenating hepatic hollow fiber bioreactors. Biotechnol Bioeng 105(3): 534-542.
7. Cho CH, Park J, Nagrath D, Tilles AW, Berthiaume F, Toner M, Yarmush ML. 2007. Oxygen uptake rates and liver-specific functions of hepatocyte and 3T3 fibroblast co-cultures. Biotechnol Bioeng 97(1): 188-199.
8. Craig DGN, Lee A, Hayes PC, Simpson KJ. 2010. Review article: The current management of acute liver failure. Aliment Pharmacol Ther 31(3): 345-358.
9. Davidson AJ, Ellis MJ, Chaudhuri JB. 2010. A theoretical method to improve and optimize the design of bioartificial livers. Biotechnol Bioeng 106(6): 980-988.
10. De Groot H, Littauer A, Noll T. 1988. Metabolic and pathological aspects of hypoxia in liver cells. In: Acker H, editor. Oxygen sensing in tissue. New York: Springer-Verlag. p 49-64.
11. Demetriou AA, Lerut J, Brown RS, Busuttil RW, Fair J, McGuire BM, Rosenthal P, Esch JSA, Nyberg SL, Salizzoni M, Fagan EA, De Hemptinne B, Broelsch CE, Muraca M, Salmeron JM, Rabkin JM, Metselaar HJ, Pratt D, De La Mata M, McChesney LP, Everson GT, Lavin PT, Stevens AC, Pitkin Z, Solomon, BA. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure; 2003 Nov 30-Dec 03. Hot Springs, VA: Lippincott Williams & Wilkins. p 660-667.
12. Gebhardt R. 1992. Metabolic zonation of the liver-Regulation and implications for liver-function. Pharmacol Ther 53(3): 275-354.
13. Gerlach J, Trost T, Ryan CJ, Meissler M, Hole O, Muller C, Neuhaus P. 1994. Hybrid liver support system in a short-term application on hepatectomized pigs. Int J Artif Organs 17(10): 549-553.
14. Hay PD, Veitch AR, Smith MD, Cousins RB, Gaylor JDS. 2000. Oxygen transfer in a diffusion-limited hollow fiber bioartificial liver. Artif Organs 24(4): 278-288.
15. Hay PD, Veitch AR, Gaylor JDS. 2001. Oxygen transfer in a convection-enhanced hollow fiber bioartificial liver. Artif Organs 25(2): 119-130.
16. Jungermann K, Kietzmann T. 2000. Oxygen: Modulator of metabolic zonation and disease of the liver. Hepatology 31(2): 255-260.
17. Kietzmann T, Jungermann K. Modulation by oxygen of zonal gene expression in liver studied in primary rat hepatocyte cultures; 1996 Sep 25-28 Jul 1997. Tubingen, Germany: Kluwer Academic Publ. p 243-255.
18. Krogh A. 1919. The number and distribution of capillaries in muscles with calculations of the oxygen pressure head necessary for supplying the tissue. J Physiol 52(6): 409-415.
19. Lee WM, Squires RH, Nyberg SL, Doo E, Hoofnagle JH. 2008. Acute liver failure: Summary of a workshop. Hepatology 47(4): 1401-1415.
20. Miyazaki M, Bai L, Tsuboi S, Seshimo K, Namba M. 1991. Effects of anitoxidants on survival of adult rat hepatocytes under various oxygen-tensions in serum-free primary culture. Acta Med Okayama 45(6): 441-444.
21. Morelli S, Salerno S, Rende M, Lopez LC, Favia P, Procino A, Mernoli B, Andreucci VE, d'Agostino R, Drioli E, De Bartolo L. 2007. Human hepatocyte functions in a galactosylated membrane bioreactor. J Membr Sci 302(1-2): 27-35.
22. Moussy Y. 2003. Convective flow through a hollow fiber bioartificial liver. Artif Organs 27(11): 1041-1049.
23. Nyberg SL, Remmel RP, Mann HJ, Peshwa MV, Hu WS, Cerra FB. 1994. Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver. Ann Surg 220(1): 59-67.
24. Patzer JF. 2004. Oxygen consumption in a hollow fiber bioartificial liver-revisited. Artif Organs 28(1): 83-98.
25. Piret JM, Cooney CL. 1991. Model of oxygen-transport limitations in hollow fiber bioreactors. Biotechnol Bioeng 37(1): 80-92.
26. Pless G, Sauer IM. 2005. Bioartificial liver: Current status. Transplant Proc 37(9): 3893-3895.
27. Rappaport AM. 1976. The microcirculatory acinar concept of normal and pathological hepatic structure. Beitr Path Bd 157: 215-243.
28. Rozga J, Holzman MD, Ro MS, Griffin DW, Neuzil DF, Giorgio T, Moscioni AD, Demetriou AA, Myers WC, Flye MW. Development of a Hybrid Bioartificial Liver; 1992 Dec 07. Aventura, FL: Lippincott-Raven Publ. p 502-511.
29. Sauer IM, Kardassis D, Zeillinger K, Pascher A, Gruenwald A, Pless G, Irgang M, Kraemer M, Puhl G, Frank J, Müller AR, Steinmüller TH, Denner J, Neuhaus P, Gerlach JC. 2003. Clinical extracorporeal hybrid liver support-Phase I study with primary porcine liver cells. Xenotransplantation 10(5): 460-469.
30. Saxena R, Zucker SD, Crawford JM. 2003. Anatomy and physiology of the liver. In: Zakim D, Boyer TD, editors. Hepatology: A textbook of liver disease, 4th edn. Philadelphia; London: Saunders. p 3-30.
31. Sullivan JP, Palmer AF. 2006. Targeted oxygen delivery within hepatic hollow fiber bioreactors via supplementation of hemoglobin-based oxygen carriers. Biotechnol Prog 22(5): 1374-1387.
32. Sullivan JP, Gordon JE, Bou-Akl T, Matthew HWT, Palmer AF. 2007. Enhanced oxygen delivery to primary hepatocytes within a hollow fiber bioreactor facilitated via hemoglobin-based oxygen carriers. Artif Cells Blood Substit Biotechnol 35(6): 585-606.
33. Sussman NL, Koussayer T, He DE, Kelly JH. 1991. Rescue from fulminant hepatic-failure with an extracorporeal liver assist device (ELAD). Hepatology 14(4): A95-A95.
34. Telford IR, Bridgman CF. 1995. Digestive system III-Pancreas, liver, and biliary tract. Introduction to functional histology, 2nd edn. New York: HarperCollins College Publishers. p 333-353.
35. van de Kerkhove MP, Hoekstra R, Chamuleau RAFM, van Gulik TM. 2004. Clinical application of bioartificial liver support systems. Ann Surg 240(2): 216-230.
36. Wigg AJ, Padbury RT. 2005. Liver support systems: Promise and reality. J Gastroenterol Hepatol 20(12): 1807-1816.
37. Xue YL, Zhao SF, Luo Y, Li XJ, Duan ZP, Chen XP, Li WG, Huang XQ, Li YL, Cui X, Zhong DG, Zhang ZY, Huang ZQ. 2001. TECA hybrid artificial liver support system in treatment of acute liver failure. World J Gastroenterol 7(6): 826-829.
38. Yu CB, Pan XP, Li LJ. 2009. Progress in bioreactors of bioartificial livers. Hepatobiliary Pancreat Dis Int 8(2): 134-140.